• Journal of Microbiology
• /
• v.45 no.2
• /
• pp.146-152
• /
• 2007

A mutant exhibiting decreased cytotoxic activity toward INT-407 intestinal epithelial cells and carrying a mutation in the rtx gene cluster that consists of rtxCA and rtxBDE operons was screened from a library of V. vulnificus mutants. The functions of the rtxA gene, assessed by constructing an isogenic mutant and evaluating its phenotypic changes, demonstrated that RtxA is essential for the virulence of V. vulnificus in mice as well as in tissue cultures.

• Childhood Kidney Diseases
• /
• v.22 no.1
• /
• pp.1-6
• /
• 2018

Rituximab (RTX) is a chimeric monoclonal antibody that inhibits CD20-mediated B-cell proliferation and differentiation. Several studies have examined its use in intractable nephrotic syndrome (NS) with some positive results. However, those studies examined such effects for a short-term period of 1 year, and some patients continued to relapse after a lapse in RTX treatment. Our use of RTX as a maintenance therapy (RTX injection when the CD19 cell count exceeded $100-200/{\mu}L$ before relapse) showed some noticeable efficacy. We used RTX in 19 patients with steroid-dependent NS (SDNS). In 12 patients treated with RTX maintenance therapy, only one relapse occurred. The mean treatment period was $23.4{\pm}12.7months$, and the mean number of RTX administrations was $3.9{\pm}1.6$. The relapse rates were decreased (from 2.68/year to 0.04/year), and the drug-free period also increased (from 22.5 days/year to 357.1 days/year) during maintenance therapy. The other seven patients were treated with one cycle of RTX or additional cycles in case of relapse (non-maintenance therapy). Relapse rates were significantly decreased after RTX treatment (from 1.76/year to 0.96/year, P=0.017). The relapse-free period was $15.55{\pm}7.38$ (range, 5.3-30.7) months. No severe side effects of RTX were found except for a hypersensitivity reaction such as fever and chills during its infusion. In conclusion, RTX is considered an effective and safe option to reduce the relapse rate by a single- or maintenance-interval therapy in SDNS.

• Kidney Research and Clinical Practice
• /
• v.36 no.3
• /
• pp.257-263
• /
• 2017

Background Rituximab (RTX) can be used as a rescue therapy for steroid-dependent nephrotic syndrome (SDNS). However, the efficacy and safety of long-term, repeated use of RTX are not established. This study was conducted to assess the efficacy and safety of long-term, repeated RTX treatment in children. Methods Eighteen consecutive child patients with SDNS who were treated with three or more cycles of RTX for one year or longer were recruited, and their medical records were retrospectively reviewed. Results The patients were followed for $4.7{\pm}1.9years$ and received $5.2{\pm}2.3cycles$ of RTX over $2.8{\pm}1.1years$. Approximately 70% of the additional RTX cycles were administered due to recovery of B-cells without relapse. The relapse rate decreased from $3.4{\pm}2.0per$ year initially to $0.4{\pm}0.8per$ year at the third year after RTX treatment. Approximately 10% of the RTX infusions were accompanied by mild infusion reactions. Eight patients showed sustained remission without any oral medication after the last cycle of RTX, while 10 patients had one or more episodes of relapse after the last cycle of RTX. The relapse rate in the latter group decreased from $2.8{\pm}1.5per$ year before RTX treatment to $1.3{\pm}0.8per$ year after cessation of RTX treatment. No significant differences in clinical parameters were found between the two groups. Conclusion This retrospective study showed that pre-emptive and long-term, repeated RTX treatment is relatively effective and safe in children with SDNS. However, well-designed prospective studies are needed to confirm these findings.

• IMMUNE NETWORK
• /
• v.16 no.4
• /
• pp.233-241
• /
• 2016

DCs, like the sensory neurons, express vanilloid receptor 1 (VR1). Here we demonstrate that the VR1 agonists, capsaicin (CP) and resiniferatoxin (RTX), enhance antiviral CTL responses by increasing MHC class I-restricted viral antigen presentation in dendritic cells (DCs). Bone marrow-derived DCs (BM-DCs) were infected with a recombinant vaccinia virus (VV) expressing OVA (VV-OVA), and then treated with CP or RTX. Both CP and RTX increased MHC class I-restricted presentation of virus-encoded endogenous OVA in BM-DCs. Oral administration of CP or RTX significantly increased MHC class I-restricted OVA presentation by splenic and lymph node DCs in VV-OVA-infected mice, as assessed by directly measuring OVA peptide SIINFEKL-K^b complexes on the cell surface and by performing functional assays using OVA-specific CD8 T cells. Accordingly, oral administration of CP or RTX elicited potent OVA-specific CTL activity in VV-OVA-infected mice. The results from this study demonstrate that VR1 agonists enhance anti-viral CTL responses, as well as a neuro-immune connection in anti-viral immune responses.

• Journal of the Korea Institute of Military Science and Technology
• /
• v.14 no.3
• /
• pp.353-358
• /
• 2011

In this paper, we have introduced a Missile In the Loop Simulation(MILS) Software developed for the missile ground test, which is based on a commercial hard real-time operating system(OS) on Windows platform called as Real-Time eXtension(RTX). MILS software makes it possible to test overall system functions of a integrated missile on the ground in the flight conditions by real-time imitating its inertial data. By means of MILS, we have performed missiles ground tests, which result in successful real flight tests.

• The Korean Journal of Physiology and Pharmacology
• /
• v.20 no.1
• /
• pp.129-136
• /
• 2016

This study was performed to investigate whether an intra-articular injection of transient receptor potential vanilloid 1 (TRPV1) receptor agonist, resiniferatoxin (RTX) would alleviate behavioral signs of arthritic pain in a rat model of osteoarthritis (OA). We also sought to determine the effect of RTX treatment on calcitonin gene-related peptide (CGRP) expression in the spinal cord. Knee joint inflammation was induced by intra-articular injection of monosodium iodoacetate (MIA, $8mg/50{\mu}l$) and weight bearing percentage on right and left hindpaws during walking, paw withdrawal threshold to mechanical stimulation, and paw withdrawal latency to heat were measured to evaluate pain behavior. Intra-articular administration of RTX (0.03, 0.003 and 0.0003%) at 2 weeks after the induction of knee joint inflammation significantly improved reduction of weight bearing on the ipsilateral hindlimb and increased paw withdrawal sensitivity to mechanical and heat stimuli. The reduction of pain behavior persisted for 3~10 days according to each behavioral test. The MIA-induced increase in CGRP immunoreactivity in the spinal cord was decreased by RTX treatment in a dose-dependent manner. The present study demonstrated that a single intra-articular administration of RTX reduced pain behaviors for a relatively long time in an experimental model of OA and could normalize OA-associated changes in peptide expression in the spinal cord.

• Childhood Kidney Diseases
• /
• v.19 no.2
• /
• pp.176-179
• /
• 2015

Rituximab (RTX), a monoclonal antibody against the B-cell marker CD20, is commonly used as a treatment for antibody-mediated diseases or B-lymphocyte-mediated diseases. Destruction of B cells may reverse the disease course in many conditions; however, patients who are treated with RTX cannot respond appropriately to de novo infection due to lack of B lymphocytes. Here, we report one such case. A 7-year-old renal allograft recipient presented with severe anemia due to parvovirus infection after RTX treatment. The patient had focal segmental glomerulosclerosis and had received cadaveric kidney transplantation 6 months previously. She was treated with high-dose steroid for acute rejection and RTX for Epstein Barr Virus infection 3 months previously. At presentation, her hemoglobin level was 5.4 g/dL and leukocyte and platelet counts were normal. She had microcytic normochromic anemia and high viral load of parvovirus B19(70,578 copies/mL). Intravenous immunoglobulin ($200mg/kg{\cdot}d$) treatment controlled the progression of anemia and parvovirus infection. De novo parvovirus infection during the B lymphocyte-depletion period may have precipitated the severe anemia in this case. Close monitoring of infection is required after RTX therapy.

• KIPS Transactions on Computer and Communication Systems
• /
• v.12 no.2
• /
• pp.69-76
• /
• 2023

Hundreds of thousands of passwords are lost or forgotten every year, making the necessary information unavailable to legitimate owners or authorized law enforcement personnel. In order to recover such a password, a tool for password cracking is required. Using GPUs instead of CPUs for password cracking can quickly process the large amount of computation required during the recovery process. This paper optimizes on GPUs using CUDA, with a focus on decryption of the currently most popular PDF 1.4-1.6 version. Techniques such as eliminating unnecessary operations of the MD5 algorithm, implementing 32-bit word integration of the RC4 algorithm, and using shared memory were used. In addition, autotune techniques were used to search for the number of blocks and threads that affect performance improvement. As a result, we showed throughput of 31,460 kp/s (kilo passwords per second) and 66,351 kp/s at block size 65,536, thread size 96 in RTX 3060, RTX 3090 environments, and improved throughput by 22.5% and 15.2%, respectively, compared to the cracking tool hashcat that achieves the highest throughput.

• Journal of the Korean Society of Fisheries and Ocean Technology
• /
• v.38 no.3
• /
• pp.249-255
• /
• 2002

This paper describes on the extraction of ship's real-time movement information using a combination full-function ARPA radar and ECS system that displays radar images and an electronic chart together on a single PC screen. The radar target extractor(RTX) board, developed by Marine Electronics Corporation of Korea, receives radar video, trigger, antenna bearing pulse and heading pulse signals from a radar unit and processes these signals to extract target information. The target data extracted from each pulse repetition interval in DSPs of RTX that installed in 16 bit ISA slot of a IBM PC compatible computer is formatted into a series of radar target messages. These messages are then transmitted to the host PC and displayed on a single screen. The position data of target in range and azimuth direction are stored and used for determining the center of the distributed target by arithmetic averaging after the detection of the target end. In this system, the electronic chart or radar screens can be displayed separately or simulaneously and in radar mode all information of radar targets can be recorded and replayed In spite of a PC based radar system, all essential information required for safe and efficient navigation of ship can be provided.

• Journal of the Korea Institute of Information Security & Cryptology
• /
• v.32 no.6
• /
• pp.1035-1043
• /
• 2022

With the spread of the Internet of Things (IoT), cloud computing, and big data, the need for high-speed encryption for applications is emerging. GPU optimization can be used to validate cryptographic analysis results or reduced versions theoretically obtained by the GPU in a reasonable time. In this paper, PIPO lightweight encryption implemented in various environments was implemented on GPU. Optimally implemented considering the brute force attack on PIPO. In particular, the optimization implementation applying the bit slicing technique and the GPU elements were used as much as possible. As a result, the implementation of the proposed method showed a throughput of about 19.5 billion per second in the RTX 3060 environment, achieving a throughput of about 122 times higher than that of the previous study.